Aetna (AET) Rating Increased to Buy at ValuEngine

Aetna (NYSE:AET) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday.

A number of other research firms have also recently issued reports on AET. Zacks Investment Research upgraded Aetna from a “sell” rating to a “hold” rating in a report on Thursday, May 3rd. Credit Suisse Group lowered their target price on Aetna from $208.00 to $194.00 and set a “neutral” rating for the company in a report on Monday, May 14th. Finally, Cantor Fitzgerald upgraded Aetna from a “neutral” rating to an “overweight” rating in a report on Tuesday, May 1st. Eight equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $196.36.

Aetna opened at $188.82 on Tuesday, MarketBeat Ratings reports. The stock has a market cap of $62.01 billion, a price-to-earnings ratio of 19.15, a PEG ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.73 and a quick ratio of 0.73. Aetna has a 1 year low of $149.69 and a 1 year high of $194.40.

Aetna (NYSE:AET) last released its earnings results on Tuesday, May 1st. The company reported $3.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.97 by $0.22. The firm had revenue of $15.34 billion during the quarter, compared to analysts’ expectations of $15.32 billion. Aetna had a return on equity of 21.42% and a net margin of 5.76%. The company’s revenue was up 1.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.71 EPS. sell-side analysts forecast that Aetna will post 11.06 earnings per share for the current year.

Several institutional investors have recently bought and sold shares of AET. Farallon Capital Management LLC acquired a new position in shares of Aetna during the 4th quarter worth about $940,734,000. Summit Trail Advisors LLC boosted its stake in shares of Aetna by 55,803.4% during the 1st quarter. Summit Trail Advisors LLC now owns 1,616,727 shares of the company’s stock worth $1,617,000 after buying an additional 1,613,835 shares during the last quarter. Wells Fargo & Company MN boosted its stake in shares of Aetna by 101.0% during the 1st quarter. Wells Fargo & Company MN now owns 2,797,748 shares of the company’s stock worth $472,819,000 after buying an additional 1,405,859 shares during the last quarter. Abrams Capital Management L.P. acquired a new position in shares of Aetna during the 1st quarter worth about $233,220,000. Finally, Deutsche Bank AG boosted its stake in shares of Aetna by 57.5% during the 4th quarter. Deutsche Bank AG now owns 2,704,723 shares of the company’s stock worth $487,900,000 after buying an additional 987,156 shares during the last quarter. Institutional investors own 84.93% of the company’s stock.

About Aetna

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply